Irinotecan Hydrochloride CAS 100286-90-6 Ịdị Ọcha ≥99.0% (HPLC) API USP Standard High ịdị ọcha
Aha Chemical | Irinotecan Hydrochloride |
Ụdị okwu | Camptothecin II;CPT-II |
Nọmba CAS | 100286-90-6 |
Nọmba CAT | RF-API50 |
Ọnọdụ Ahịa | N'ọkwa, Mpụta Ihe ruru Tọn |
Usoro ihe omimi | C33H39ClN4O6 |
Ibu molekụla | 623.15 |
Ebe Na-agbaze | 250-256 ℃ (Dec.) |
Ọnọdụ Nchekwa | N'okpuru ọnọdụ okpomọkụ |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Ọcha ma ọ bụ Gbanyụọ-Ọcha ntụ ntụ |
Solubility | Soluble na mmiri na methanol, soluble ntakịrị na chloroform, ethanol |
njirimara IR | Ụdị nnabata infrared nke nlele ule kwesịrị ikwekọ na nke ọkọlọtọ ntụaka |
njirimara HPLC | Oge njide nke isi kacha elu nke ngwọta nlele kwesịrị ikwekọ na nke ọkọlọtọ ntụaka. |
njirimara | Na-emezu ihe achọrọ maka ule maka mmeghachi omume ọma Chloride |
Mmiri (KF) | 7.0% ~ 9.0% w/w |
Ihe fọdụrụ na mgbanye | ≤0.10% |
Ọla dị arọ | ≤20ppm |
Irinotecan Hydrochloride Enantiomer | ≤0.10% (HPLC) |
7-Desethyl Irinotecan | ≤0.15% |
Ihe jikọrọ Irinotecan A | ≤0.15% |
11-Ethyl Irinotecan | ≤0.15% |
Camptothecin | ≤0.15% |
Ihe jikọrọ Irinotecan B | ≤0.15% |
7-Ethylcanptothecin | ≤0.15% |
7,11-Diethyl-10-Hydroxy Camptothecin | ≤0.15% |
Ọdịghị ọcha ọ bụla akọwapụtaghị | ≤0.10% |
Mgbakọta adịghị ọcha | ≤0.50% |
Ihe mgbaze fọdụrụnụ (GC) | |
Methanol | ≤2000ppm |
Acetone | ≤2000ppm |
Dichloromethane | ≤500ppm |
Peteoleum Ether: | ≤100ppm |
Ethyl acetate | ≤2000ppm |
Benzene | ≤2pm |
Endotoxins nke nje bacteria | ≤0.29 EU/mg Irinotecan |
Oke Microbial | Ngụkọta ọnụ ọgụgụ microbial nke ikuku: <1000 cfu/g |
Ebu na yist | <100 cfu/g |
Ụzọ ịdị ọcha / nyocha | ≥99.0% (HPLC, na anhydrous ndabere) |
Nlele ọkọlọtọ | Ọkọlọtọ United States Pharmacopeia (USP). |
Ojiji | Ngwakọta ọgwụ na-arụ ọrụ (API) |
ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.
![1](https://a395.goodao.net/uploads/15.jpg)
![](https://a395.goodao.net/uploads/23.jpg)
lrinotecan hydrochloride (CAS 100286-90-6), ihe na-emepụta ihe na-emepụta mmiri na-emepụta ihe na-emepụta ihe na-eme ihe ike anticancer camptothecin, na Japan maka ọgwụgwọ nke ngụgụ, ovarian, na ọrịa cancer cervical.lrinotecan na-arụ ọrụ antitumor ya site na mgbochi nke topoisomerase I, enzyme cellular nke na-etinye aka n'ịkwado usoro nhazi nke DNA n'oge usoro ntụgharị, ntụgharị, na mitosis.lrinotecan na-enweta de-esterification na vivo iji mepụta metabolite na-arụ ọrụ, SN-38, nke nwere ike 1000 ugboro karịa nne na nna.Ngwọta ọgwụgwọ nke irinotecan na ọgwụ mgbochi ọrịa cancer ọzọ a na-ejikarị eme ihe, bụ cisplatin, ka akọọrọ na ọ dị elu karịa nke ọ bụla naanị ya.lrinotecan nọ na nnwale ụlọ ọgwụ maka eriri afọ, ara, akpụkpọ anụ, colorectal, ọrịa cancer pancreatic, mesothelioma na lymphoma na-abụghị Hodgkin.